ArrayGenomics SA - Company Review
SummaryArrayGenomics SA - Company Review
Summary
ArrayGenomics SA (ArrayGenomics) is a bioscience company that develops genomic technologies in the field of molecular diagnostics. The company’s array genomics backup CGH assay is a technology to develop non-invasive tests. Its technology offers tests for bladder cancer-BCA-1, kidney cancer-KCA-1, prostate cancer- PCA-1, colon cancer and hematology tests. ArrayGenomics offers services such as genomic profiling, cell culture, DNA extraction, DNA amplification, hybridization, pre and post natal diagnosis, hybridized array and analysis report services. The company also develops new microarray-based tests for laboratory applications. It collaborates with scientific and clinical sectors in the field of urological cancers. ArrayGenomics is headquartered in Voisins Le Bretonneux, France.
This comprehensive company report of ArrayGenomics SA provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.